中国高血压现状:2012-2015年中国高血压调查结果
结果显示23.2%的成人患高血压,41.3%为高血压前期,知晓率、治疗率和控制率分别为46.9%、40.7%和15.3%。
要点
- 中国≥18岁成人高血压患病率为23.2%,高血压前期为41.3%。
- 高血压患者知晓率46.9%,治疗率40.7%,控制率仅15.3%。
- 钙通道阻滞剂是最常用的单药治疗(46.5%),31.7%的治疗患者使用≥2种药物。
核心结论
- 中国高血压和高血压前期患病率高,而知晓、治疗和控制率低,需要改善高血压的药物治疗管理。
研究设计与样本
- 血压由培训人员使用经验证的上臂式示波法血压计在休息5分钟后测量。
- 高血压定义为收缩压≥140 mmHg和/或舒张压≥90 mmHg或2周内使用降压药物;高血压前期定义为收缩压120-139 mmHg和舒张压80-89 mmHg且未使用降压药物;控制定义为收缩压<140 mmHg且舒张压<90 mmHg。
- 另按2017年美国心脏病学会/美国心脏协会高血压指南估计高血压(收缩压≥130或舒张压≥80 mmHg)患病率及控制率(收缩压<130且舒张压<80 mmHg)。
主要发现
- 城市与农村居民高血压患病率无显著差异(23.4% vs 23.1%,P=0.819)。
- 高血压患者中46.9%知晓自身状况,40.7%服用处方降压药,15.3%血压得到控制。
- 钙通道阻滞剂是最常用的单药降压药(46.5%),31.7%的治疗高血压患者使用≥2种药物。
- 按2017年美国心脏病学会/美国心脏协会指南,高血压患病率(46.4%)是2010年中国指南的两倍,而控制率降至3.0%。
关键数值与推荐
- 高血压诊断标准:收缩压≥140 mmHg和/或舒张压≥90 mmHg或2周内使用降压药物。
- 高血压前期标准:收缩压120-139 mmHg和舒张压80-89 mmHg且未使用降压药物。
- 高血压控制标准:收缩压<140 mmHg且舒张压<90 mmHg。
- 按2017年美国心脏病学会/美国心脏协会指南,高血压标准为收缩压≥130或舒张压≥80 mmHg,控制标准为收缩压<130且舒张压<80 mmHg。
临床怎么用
- 中国成人高血压患病率高而控制率低,应加强高血压筛查、知晓和治疗管理。
- 钙通道阻滞剂是最常用单药,近三分之一治疗患者需≥2种药物,提示联合治疗常见。
- 按更严格的美國指南标准,高血压患病率更高而控制率极低,临床需关注血压达标管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although the prevalence of hypertension (HTN) continues to increase in developing countries, including China, recent data are lacking. A nationwide survey was conducted from October 2012 to December 2015 to assess the prevalence of HTN in China. METHODS: A stratified multistage random sampling method was used to obtain a nationally representative sample of 451 755 residents ≥18 years of age from 31 provinces in mainland China from October 2012 to December 2015. Blood pressure (BP) was measured after resting for 5 minutes by trained staff using a validated oscillometric BP monitor. HTN was defined as systolic BP (SBP) ≥140 mm Hg/or diastolic BP (DBP) ≥90 mm Hg or use of antihypertensive medication within 2 weeks. Pre-HTN was defined as SBP 120 to 139 mm Hg and DBP 80 to 89 mm Hg without antihypertensive medication. HTN control was defined as SBP <140 mm Hg and DBP<90 mm Hg. In addition, the prevalence of HTN (SBP ≥130 or DBP ≥80 mm Hg) and control rate (SBP <130 and DBP <80 mm Hg) of HTN were also estimated according to the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. RESULTS: Overall, 23.2% (≈244.5 million) of the Chinese adult population ≥18 years of age had HTN, and another 41.3% (≈435.3 million) had pre-HTN according to the Chinese guideline. There were no significant differences of HTN prevalence between urban and rural residents (23.4% versus 23.1%, P=0.819). Among individuals with HTN, 46.9% were aware of their condition, 40.7% were taking prescribed antihypertensive medications, and 15.3% had controlled HTN. Calcium channel blockers were the most commonly used antihypertensive medication (46.5%) as monotherapy, and 31.7% of treated hypertensive patients used ≥2 medications. The prevalence of HTN based on the 2017 American College of Cardiology/American Heart Association guideline was twice as high as that based on 2010 Chinese guideline (46.4%), whereas the control rate fell to 3.0%. CONCLUSIONS: In China, there is a high prevalence of HTN and pre-HTN, and awareness, treatment, and control of HTN were low. Management of medical therapy for HTN needs to improve.
引用
- Wang Z, Chen Z, Zhang L, et al. Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015. Circulation. 2018. PMID: 29449338. doi:10.1161/CIRCULATIONAHA.117.032380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。